A Maryland law prohibiting "price gouging" in the sale of certain off-patent and generic drugs is to go into effect Oct. 1, after a court found the Association for Accessible Medicines had not shown it is likely to be held unconstitutional.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?